BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18380944)

  • 1. Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products.
    Li J; Liu NF; Wei Q
    J Int Med Res; 2008; 36(2):329-35. PubMed ID: 18380944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
    Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
    Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P
    Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression.
    Sun K; Wang Q; Huang XH
    Acta Pharmacol Sin; 2006 Jun; 27(6):715-23. PubMed ID: 16723090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.
    Liang C; Ren Y; Tan H; He Z; Jiang Q; Wu J; Zhen Y; Fan M; Wu Z
    Br J Pharmacol; 2009 Dec; 158(8):1865-73. PubMed ID: 19917066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.
    Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP
    Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of PPAR-γ inhibits differentiation of rat osteoblasts by reducing expression of connective tissue growth factor.
    Yu WW; Xia Q; Wu Y; Bu QY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):652-656. PubMed ID: 25318873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of rosiglitazone on the expression connective tissue growth factor in tubulointerstitium in KKA(y) mice].
    Qin Y; Li XW; Wen YB; Li H; Chen LM; Duan L; Li Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):817-21. PubMed ID: 17260474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells.
    Yan HD; Li XZ; Xie JM; Li M
    Chin Med J (Engl); 2007 May; 120(9):787-93. PubMed ID: 17531120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts.
    Twigg SM; Joly AH; Chen MM; Tsubaki J; Kim HS; Hwa V; Oh Y; Rosenfeld RG
    Endocrinology; 2002 Apr; 143(4):1260-9. PubMed ID: 11897682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
    Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
    Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin and connective tissue growth factor in advanced glycation end-product-induced effects in NRK-49F cells.
    Lee CI; Guh JY; Chen HC; Lin KH; Yang YL; Hung WC; Lai YH; Chuang LY
    J Cell Biochem; 2004 Nov; 93(5):940-50. PubMed ID: 15389880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats.
    Ahmed MS; Øie E; Vinge LE; Yndestad A; Øystein Andersen G; Andersson Y; Attramadal T; Attramadal H
    J Mol Cell Cardiol; 2004 Mar; 36(3):393-404. PubMed ID: 15010278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts.
    Wang B; Haldar SM; Lu Y; Ibrahim OA; Fisch S; Gray S; Leask A; Jain MK
    J Mol Cell Cardiol; 2008 Aug; 45(2):193-7. PubMed ID: 18586263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus.
    Twigg SM; Chen MM; Joly AH; Chakrapani SD; Tsubaki J; Kim HS; Oh Y; Rosenfeld RG
    Endocrinology; 2001 May; 142(5):1760-9. PubMed ID: 11316739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury.
    Rehan VK; Sakurai R; Corral J; Krebs M; Ibe B; Ihida-Stansbury K; Torday JS
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L672-80. PubMed ID: 20729387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ).
    Chen M; Li H; Wang G; Shen X; Zhao S; Su W
    Metabolism; 2016 Apr; 65(4):441-53. PubMed ID: 26975536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone inhibits migration, proliferation, and phenotypic differentiation in cultured human lung fibroblasts.
    Lin Q; Fang LP; Zhou WW; Liu XM
    Exp Lung Res; 2010 Mar; 36(2):120-8. PubMed ID: 20205597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
    Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME
    Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.